Cargando…

Transplantation of Encapsulated Dopamine-Secreting Cells as a Treatment for Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Emerich, D. F., Flanagan, T. R., Frydel, B. R., Gentile, F. T., Palmatier, M. A., Winn, S. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565189/ http://dx.doi.org/10.1155/NP.1992.267

Ejemplares similares

Combination of cell transplantation and glial cell line-derived neurotrophic factor-secreting encapsulated cells in Parkinson's disease
por: Widmer, Hans R.
Publicado: (2018)

Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model
por: Wolff, Erin F, et al.
Publicado: (2011)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
por: Iarkov, Alexandre, et al.
Publicado: (2020)

Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease
por: Lelos, M.J., et al.
Publicado: (2016)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease
por: Ming, Ming, et al.
Publicado: (2009)

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
por: Ritz, Beate R., et al.
Publicado: (2009)

Habitual behavior and dopamine cell vulnerability in Parkinson disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Schizotypy in Parkinson’s disease predicts dopamine-associated psychosis
por: Oehrn, Carina R., et al.
Publicado: (2021)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

Dopamine and Acetylcholine, a Circuit Point of View in Parkinson’s Disease
por: Rizzi, Giorgio, et al.
Publicado: (2017)

Speech-based characterization of dopamine replacement therapy in people with Parkinson’s disease
por: Norel, R., et al.
Publicado: (2020)

Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease
por: Policastro, Gabriella, et al.
Publicado: (2020)

Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
por: O'Gorman Tuura, Ruth L., et al.
Publicado: (2018)

Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities
por: Uhl, George R.
Publicado: (2019)

The Impact of Dopamine on Insulin Secretion in Healthy Controls
por: Underland, Lisa J., et al.
Publicado: (2018)

Dopamine agonist treatment increases sensitivity to gamble outcomes in the hippocampus in de novo Parkinson’s disease
por: van der Vegt, Joyce P.M., et al.
Publicado: (2020)

Effects of Dopamine on Sensitivity to Social Bias in Parkinson's Disease
por: Djamshidian, Atbin, et al.
Publicado: (2012)

CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease
por: Pakarinen, Emmi, et al.
Publicado: (2023)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
por: Masato, Anna, et al.
Publicado: (2019)

Dopamine-Secreting Pheochromocytoma and Paraganglioma
por: Miyamoto, Shotaro, et al.
Publicado: (2021)

Autologous iPSC-derived dopamine neuron transplantation in a nonhuman primate Parkinson’s disease model
por: Wang, Shuyan, et al.
Publicado: (2015)

Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
por: Gandhi, Sonia, et al.
Publicado: (2012)

Dopamine genetic risk score predicts impulse control behaviors in Parkinson’s disease
por: Hall, Alison, et al.
Publicado: (2021)

Dopamine Neuron Challenge Test for early detection of Parkinson’s disease
por: Zhou, Jingheng, et al.
Publicado: (2021)

Widespread Striatal Delivery of GDNF from Encapsulated Cells Prevents the Anatomical and Functional Consequences of Excitotoxicity
por: Emerich, Dwaine F., et al.
Publicado: (2019)

Sensory attenuation in Parkinson’s disease is related to disease severity and dopamine dose
por: Wolpe, Noham, et al.
Publicado: (2018)

Effects of dopamine on reinforcement learning in Parkinson’s disease depend on motor phenotype
por: van Nuland, Annelies J, et al.
Publicado: (2020)

Dopamine D(1) Agonists: First Potential Treatment for Late-Stage Parkinson’s Disease
por: Lewis, Mechelle M., et al.
Publicado: (2023)

Dopamine and the Biology of Creativity: Lessons from Parkinson’s Disease
por: Lhommée, Eugénie, et al.
Publicado: (2014)

The Role of Dopamine Replacement on the Behavioural Phenotype of Parkinson’s Disease
por: Alobaidi, Hajar, et al.
Publicado: (2013)

The Convergence of Dopamine and α-Synuclein: Implications for Parkinson’s Disease
por: Mor, Danielle E, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_igdg16tpebed69pppjjc3f4bqa